Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope M30 in critically ill patients

Shock

Volumn 22, Issue 3, 2004, Pages 218-220

  Roth, Georg Alexander ^a   Krenn, Claus ^a   Brunner, Markus ^a   Moser, Bernhard ^c   Ploder, Martin ^a   Spittler, Andreas ^a   Pelinka, Linda ^b   Sautner, Thomas ^a   Wolner, Ernst ^a   Boltz Nitulescu, George ^a   Ankersmit, Hendrik J ^a,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AUVA Soziale Unfallversicherung   (Austria)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Gut; Intestinal tract; Programmed cell death; Trauma

Indexed keywords

CASPASE; CYTOKERATIN 18; EPITOPE; M30 NEOANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HUMAN; INJURY; INTESTINE INJURY; MALE; MULTIPLE ORGAN FAILURE; PATHOGENESIS; PERITONITIS; PNEUMONIA; RANK SUM TEST; SEPSIS; SERUM; TRAFFIC ACCIDENT;

ADULT; BIOLOGICAL MARKERS; EPITOPES; FEMALE; HUMANS; KERATINS; MALE; MIDDLE AGED; REFERENCE VALUES; RETROSPECTIVE STUDIES; SEPSIS; WOUNDS AND INJURIES;

EID: 4544321561     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000136098.49672.0e     Document Type: Article

References (20)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
2. Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA: Post-injury multiple organ failure: the role of the gut. Shock 15:1-10, 2001.
3. Baue AE: MOF/MODS, SIRS: an update. Shock 6:S1-S5, 1996.
4. Mainous MR, Ertel W, Chaudry IH, Deitch EA: The gut: a cytokine-generating organ in systemic inflammation? Shock 4:193-199, 1995.
5. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27:1230-1251, 1999.
6. Hotchkiss RS, Schmieg RE Jr, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Karl IE, Buchman TG: Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med 28:3207-3217, 2000.
7. Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF, Zollner KM, Buchman TG, Korsmeyer SJ, Karl IE: Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 162:4148-156, 1999.
8. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM 2nd, Buchman TG, Karl IE, Hotchkiss RS: Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287:1716-1721, 2002.
9. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326:1-16, 1997.
10. Roth G, Moser B, Krenn C, Brunner M, Haisjackl M, Almer G, Gerlitz S, Wolner E, Boltz-Nitulescu G, Ankersmit HJ: Susceptibility to programmed cell death in T lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun 5:840-846, 2003.
11. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B: The biochemistry of programmed cell death. FASEB J 9:1277-1287, 1995.
12. Caulin C, Salvesen GS, Oshima RG: Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 138:1379-1394, 1997.
13. Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, Bjorklund P, Ramaekers FC, Bjorklund B, Nap M, Jornvall H, Schutte B: Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187:567-572, 1999.
14. Hagg M, Biven K, Ueno T, Rydlander L, Bjorklund P, Wiman KG, Shoshan M, Linder S: A novel high-throughput assay for screening of pro-apoptotic drugs. Invest New Drugs 20:253-259, 2002.
15. Chiu PM, Ngan YS, Khoo US, Cheung AN: Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology 38:243-249, 2001.
16. Jordan JA, Butchko AR: Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome: assessment by the caspase-related M30 Cytodeath antibody. Placenta 23:547-553, 2002.
17. Ueno T, Toi M, Biven K, Bando H, Ogawa T, Linder S: Measurement of an apoptotic product in the sera of breast cancer patients. Eur J Cancer 39:769-774, 2003.
18. Kinloch RA, Treherne JM, Furness LM, Hajimohamadreza I: The pharmacology of apoptosis. Trends Pharmacol Sci 20:35-42, 1999.
19. Wattanasirichaigoon S, Menconi MJ, Delude RL, Fink MP: Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. Shock 12:127-133, 1999.
20. Magnotti LJ, Upperman JS, Xu DZ, Lu Q, Deitch EA: Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 228:518-527, 1998.